Insilico Medicine Analysis: $510M Raised
What is Insilico Medicine?
Generative AI for drug discovery and sustainability
Location
Seattle, United States
Employees
1-10
Founded
2003
Product Features & Capabilities
- PandaOmics
- PandaOmics Box
- Chemistry42
- Generative Biologics
- Science42: DORA
- inClinico
- PreciousGPT
Use Cases
Identify new drug targets using AI; Automate drug discovery processes; Generate biologics for therapeutic applications; Conduct in-depth chemical analysis; Model diseases for better treatment strategies
Other Considerations
Recognized as the most innovative biotechnology company in the world 2024; Engaged in over 20 drug discovery programs; Collaborates with major global enterprises; Holds multiple proprietary technologies in AI-driven drug discovery
See something that needs updating? Suggest edits to this profile.